Research programme: vaccines - Eyegene

Drug Profile

Research programme: vaccines - Eyegene

Alternative Names: Influenza virus vaccine - Eyegene; Tuberculosis vaccine - Eyegene

Latest Information Update: 20 May 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator EyeGene
  • Class Bacterial vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Tuberculosis
  • Research Influenza virus infections

Most Recent Events

  • 20 May 2016 This programme is still active
  • 01 Jan 2014 Early research in Influenza virus infections in South Korea (Parenteral)
  • 01 Jan 2014 Preclinical trials in Tuberculosis in South Korea (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top